Merck’s $6.7bn Terns Pharmaceuticals buy puts CML drug TERN-701 in play as Keytruda patent cliff nears
Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Read More 2 minute read Pharma Industry News Zydus Lifesciences bags FDA approval for Lacosamide Tablets in seizures Zydus Lifesciences Limited, a prominent player in the pharmaceutical industry, has recently received final approval from the United… byPallavi MadhirajuDecember 16, 2023